BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30402208)

  • 1. Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of
    Khan MT; Rehaman AU; Junaid M; Malik SI; Wei DQ
    Comput Struct Biotechnol J; 2018; 16():379-387. PubMed ID: 30402208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
    Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ
    Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance.
    Khan MT; Malik SI
    J Biomol Struct Dyn; 2020 Jul; 38(10):3003-3017. PubMed ID: 31357912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic analysis of A46V, H57Y, and D129N in pyrazinamidase associated with pyrazinamide resistance.
    Khan MT; Chinnasamy S; Cui Z; Irfan M; Wei DQ
    Saudi J Biol Sci; 2020 Nov; 27(11):3150-3156. PubMed ID: 33100877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
    Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
    Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazinamide resistance and mutations L19R, R140H, and E144K in Pyrazinamidase of Mycobacterium tuberculosis.
    Khan MT; Junaid M; Mao X; Wang Y; Hussain A; Malik SI; Wei DQ
    J Cell Biochem; 2019 May; 120(5):7154-7166. PubMed ID: 30485476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free energy landscape and thermodynamics properties of novel mutations in PncA of pyrazinamide resistance isolates of
    Tahir Khan M; Dumont E; Chaudhry AR; Wei DQ
    J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37837425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of
    Mehmood A; Khan MT; Kaushik AC; Khan AS; Irfan M; Wei DQ
    Front Bioeng Biotechnol; 2019; 7():404. PubMed ID: 31921809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant
    Hameed HA; Tan Y; Islam MM; Lu Z; Chhotaray C; Wang S; Liu Z; Fang C; Tan S; Yew WW; Zhong N; Liu J; Zhang T
    Infect Drug Resist; 2020; 13():217-227. PubMed ID: 32158237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis.
    Rehman AU; Khan MT; Liu H; Wadood A; Malik SI; Chen HF
    J Chem Inf Model; 2019 Apr; 59(4):1584-1597. PubMed ID: 30810312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazinamide resistance of novel mutations in
    Ali A; Khan MT; Khan A; Ali S; Chinnasamy S; Akhtar K; Shafiq A; Wei DQ
    RSC Adv; 2020 Sep; 10(58):35565-35573. PubMed ID: 35515677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N.
    Junaid M; Khan MT; Malik SI; Wei DQ
    J Chem Inf Model; 2019 Jan; 59(1):498-508. PubMed ID: 30481017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis.
    Zhang S; Chen J; Shi W; Liu W; Zhang W; Zhang Y
    Emerg Microbes Infect; 2013 Jun; 2(6):e34. PubMed ID: 26038471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance.
    Khan MT; Ali S; Zeb MT; Kaushik AC; Malik SI; Wei DQ
    Front Mol Biosci; 2020; 7():52. PubMed ID: 32328498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant
    Liu B; Su P; Hu P; Yan M; Li W; Yi S; Chen Z; Zhang X; Guo J; Wan X; Wang J; Gong D; Bai H; Wan K; Liu H; Li G; Tan Y
    Infect Drug Resist; 2024; 17():403-416. PubMed ID: 38328339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of pyrazinamidase activity using a cell-free
    Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
    Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.